Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 5.58% vs -0.11% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -14.53% vs 25.32% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -23.34% vs -19.59% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -7.88% vs 27.94% in Mar 2024
Compare Profit and Loss Results of Par Drugs & Che.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
865.00
-752.00
-86.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
12.00
0.00
12.00
0%
Net Sales
100.00
865.00
-765.00
-88.44%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-9.00
8.00
88.89%
Raw Materials Consumed
39.00
722.00
-683.00
-94.60%
Power & Fuel Cost
19.00
41.00
-22.00
-53.66%
Employee Cost
5.00
35.00
-30.00
-85.71%
Operating Expenses
6.00
54.00
-48.00
-88.89%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
6.00
3.00
50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
860.00
-779.00
-90.58%
Operating Profit (PBDIT) excl Other Income
19.00
5.00
14.00
280.00%
Other Income
2.00
1.00
1.00
100.00%
Operating Profit (PBDIT)
21.00
7.00
14.00
200.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
21.00
7.00
14.00
200.00%
Depreciation
3.00
5.00
-2.00
-40.00%
Profit Before Taxation & Exceptional Items
17.00
1.00
16.00
1,600.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
1.00
16.00
1,600.00%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
13.00
1.00
12.00
1,200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
62.00
59.00
3.00
5.08%
Profit Available for appropriations
75.00
60.00
15.00
25.00%
Appropriations
75.00
60.00
15.00
25.00%
Equity Dividend (%)
0%
5%
-5.00
Earnings Per Share
10.86
1.15
9.71
844.35%
Profit And Loss - Net Sales
Net Sales 100.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5.58% vs -0.11% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.53% vs 25.32% in Mar 2024
Profit And Loss - Interest
Interest 0.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -23.34% vs -19.59% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 13.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.88% vs 27.94% in Mar 2024






